Heier, Jeffrey S <br/><br/>
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.  [electronic resource] 

 -  Ophthalmology  Apr 2006 
 - 633.e1-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2005.10.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Choroidal Neovascularization--drug therapy<br/>Cross-Over Studies<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fundus Oculi<br/>Humans<br/>Injections<br/>Intraocular Pressure<br/>Macular Degeneration--complications<br/>Male<br/>Ranibizumab<br/>Retreatment<br/>Visual Acuity--physiology<br/>Vitreous Body